本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Alpha Tau Medical

14.69
+0.26001.80%
成交量:21.10萬
成交額:306.65萬
市值:13.56億
市盈率:-13.97
高:14.84
開:14.11
低:14.11
收:14.43
52周最高:15.17
52周最低:3.43
股本:9,233.29萬
流通股本:6,379.44萬
量比:0.70
換手率:0.33%
股息:- -
股息率:- -
每股收益(TTM):-1.0517
每股收益(LYR):-0.5300
淨資產收益率:-141.68%
總資產收益率:-25.71%
市淨率:30.79
市盈率(LYR):-27.72

資料載入中...

2025/06/30

SEC問詢函

Form CORRESP - Correspondence
2025/03/12

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/12

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/03/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/07

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/07

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/12/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/09/20

SEC問詢函

Form CORRESP - Correspondence
2023/06/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/06/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/06/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/06/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/06/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/04/11

SEC問詢函

CORRESP [Cover] - Correspondence
2023/03/23

[修訂]年度報告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/03/09

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/03/09

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/05/18

SEC問詢函

CORRESP [Cover] - Correspondence
2022/05/03

SEC問詢函

CORRESP [Cover] - Correspondence